Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $315,237 - $391,898
1,300 New
1,300 $319,000
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $482,886 - $725,237
-3,700 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $828,412 - $1.16 Million
-5,200 Reduced 58.43%
3,700 $631,000
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $211,067 - $335,076
1,200 Added 15.58%
8,900 $1.58 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $1.43 Million - $1.62 Million
5,700 Added 285.0%
7,700 $2.01 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $552,780 - $724,500
2,000 New
2,000 $571,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.